A previous study attempted to identify potential therapeutic target genes for HCC by using Gene Expression Omnibus (GEO) and The Cancer Genome Atlas (TCGA) databases [23], and FGL1 was identified as a possible biomarker in lung adenocarcinoma [24]. The gene discussed is FGL1; the disease is hepatocellular carcinoma.